Literature DB >> 17001648

Synthesis and characterization of biocompatible Fe3O4 nanoparticles.

Jing Sun1, Shaobing Zhou, Peng Hou, Yuan Yang, Jie Weng, Xiaohong Li, Mingyuan Li.   

Abstract

In this study, magnetite (Fe3O4) nanoparticles with a size range of 8-20 nm were prepared by the modified controlled chemical coprecipitation method from the solution of ferrous/ferric mixed salt-solution in alkaline medium. In the process, two kinds of surfactant (sodium oleate and polyethylene glycol) were studied; then, sodium oleate was chosen as the apt surfactant to attain ultrafine, nearly spherical and well-dispersed (water-base) Fe3O4 nanoparticles, which had well magnetic properties. The size and size distribution of nanoparticles were determined by particle size analyzer. And the magnetite nanoparticles was characterized by X-ray powder diffraction (XRD) analysis, transmission electron microscopy (TEM), electron diffraction (ED) photography, Fourier transform infrared spectrometer (FT-IR), and vibrating-sample magnetometer (VSM). Also the effect of many parameters on the Fe3O4 nanoparticles was studied, such as reaction temperature, pH of the solution, stirring rate and concentration of sodium oleate. And the 5-dimethylthiazol-2-yl-2,5- diphenyltetrazolium bromide (MTT) assay was performed to evaluate the biocompatibility of magnetite nanoparticles. The results showed that the Fe3O4 nanoparticles coated by sodium oleate had a better biocompatibility, better magnetic properties, easier washing, lower cost, and better dispersion than the magnetite nanoparticles coated by PEG. Copyright 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17001648     DOI: 10.1002/jbm.a.30909

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  42 in total

1.  Electrochemical immunoassay for lactalbumin based on the use of ferrocene-modified gold nanoparticles and lysozyme-modified magnetic beads.

Authors:  Abdelmoneim Mars; Sinda Ben Jaafar; Amel Ben Ammar-El Gaied; Noureddine Raouafi
Journal:  Mikrochim Acta       Date:  2018-09-07       Impact factor: 5.833

2.  Activatable interpolymer complex-superparamagnetic iron oxide nanoparticles as magnetic resonance contrast agents sensitive to oxidative stress.

Authors:  Eunsoo Yoo; Huaitzung A Cheng; Lauren E Nardacci; David J Beaman; Charles T Drinnan; Carmen Lee; Kenneth W Fishbein; Richard G Spencer; Omar Z Fisher; Amber L Doiron
Journal:  Colloids Surf B Biointerfaces       Date:  2017-07-18       Impact factor: 5.268

3.  Polyethylenimine functionalized magnetic nanoparticles as a potential non-viral vector for gene delivery.

Authors:  Yangbo Zhou; Zhaomin Tang; Chunli Shi; Shuai Shi; Zhiyong Qian; Shaobing Zhou
Journal:  J Mater Sci Mater Med       Date:  2012-07-24       Impact factor: 3.896

4.  Magnetic nanoparticles and magnetic particle spectroscopy-based bioassays: a 15 year recap.

Authors:  Kai Wu; Jinming Liu; Vinit Kumar Chugh; Shuang Liang; Renata Saha; Venkatramana D Krishna; Maxim C-J Cheeran; Jian-Ping Wang
Journal:  Nano Futures       Date:  2022-04-07

5.  Insights into the synthesis of layered double hydroxide (LDH) nanoparticles: Part 1. Optimization and controlled synthesis of chloride-intercalated LDH.

Authors:  Xiaodi Sun; Erica Neuperger; Sandwip K Dey
Journal:  J Colloid Interface Sci       Date:  2015-08-05       Impact factor: 8.128

6.  Enhanced oxygen transfer rate and bioprocess yield by using magnetite nanoparticles in fermentation media of erythromycin.

Authors:  Ghazal Labbeiki; Hossein Attar; Amir Heydarinasab; Sayed Sorkhabadi; Alimorad Rashidi
Journal:  Daru       Date:  2014-09-16       Impact factor: 3.117

7.  Magnetic nanoparticle formulation for targeted delivery of chemotherapeutic irinotecan to lungs.

Authors:  Pushkar Kulkarni; Marina Rajadurai; Aarti Sevilimedu; Surendar Basaveni; Swapna Yellanki; Raghavender Medishetti; Uday Saxena
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

8.  Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle.

Authors:  Jyh-Ping Chen; Pei-Ching Yang; Yunn-Hwa Ma; Su-Ju Tu; Yu-Jen Lu
Journal:  Int J Nanomedicine       Date:  2012-09-27

9.  Biocompatibility of Fe₃O₄@Au composite magnetic nanoparticles in vitro and in vivo.

Authors:  Yuntao Li; Jing Liu; Yuejiao Zhong; Jia Zhang; Ziyu Wang; Li Wang; Yanli An; Mei Lin; Zhiqiang Gao; Dongsheng Zhang
Journal:  Int J Nanomedicine       Date:  2011-11-09

10.  Application of ferriferous oxide modified by chitosan in gene delivery.

Authors:  Yu Kuang; Tun Yuan; Zhongwei Zhang; Mingyuan Li; Yuan Yang
Journal:  J Drug Deliv       Date:  2012-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.